Clinical impact of human metapneumovirus infections before and during the COVID-19 pandemic.
Mandy JongbloedWouter T LeijteCatharina F M LinssenBernadette G van den HoogenEric C M van GorpMartijn D de KruifPublished in: Infectious diseases (London, England) (2021)
The clinical impact of HMPV infection did not change during the COVID-19 outbreak in terms of incidence and/or disease severity; hence, HMPV and SARS-CoV-2 are probably co-circulating independently. Despite the current clinical focus on the COVID-19 pandemic, clinicians should keep in mind that HMPV-infection may mimic COVID-19 and is also associated with serious adverse outcomes.